ulipristal acetate   Click here for help

GtoPdb Ligand ID: 7460

Synonyms: CDB-2914 | EllaOne® | VA2914
Approved drug PDB Ligand
ulipristal acetate is an approved drug (EMA (2009), FDA (2010))
Comment: Ulipristal acetate is a selective progesterone receptor modulator (SPRM) contained in certain emergency contraceptives.
Click here for help
IUPHAR Pharmacology Education Project (PEP) logo

View more information in the IUPHAR Pharmacology Education Project: ulipristal acetate

2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 5
Hydrogen bond donors 0
Rotatable bonds 5
Topological polar surface area 63.68
Molecular weight 475.27
XLogP 4.18
No. Lipinski's rules broken 0
Click here for help
Canonical SMILES CC(=O)OC1(CCC2C1(C)CC(c1ccc(cc1)N(C)C)C1=C3CCC(=O)C=C3CCC21)C(=O)C
Isomeric SMILES CC(=O)O[C@@]1(CC[C@@H]2[C@]1(C)C[C@H](c1ccc(cc1)N(C)C)C1=C3CCC(=O)C=C3CC[C@@H]21)C(=O)C
InChI InChI=1S/C30H37NO4/c1-18(32)30(35-19(2)33)15-14-27-25-12-8-21-16-23(34)11-13-24(21)28(25)26(17-29(27,30)3)20-6-9-22(10-7-20)31(4)5/h6-7,9-10,16,25-27H,8,11-15,17H2,1-5H3/t25-,26+,27-,29-,30-/m0/s1
No information available.
Summary of Clinical Use Click here for help
Approved uses: ulipristal acetate is indicated for pre-operative treatment of moderate to severe symptoms of uterine fibroids in adult women of reproductive age and as an emergency contraceptive (to be taken within 120 hours of unprotected sex or contraceptive failure).
Mechanism Of Action and Pharmacodynamic Effects Click here for help
Ulipristal acetate is a progesterone receptor modulator. It has partial agonist and antagonist activity at the progesterone receptor [1]. Use of the drug delays ovulation and inhibits maturation of the uterine endometrium meaning that implantation is less likely.
External links Click here for help